Cargando…

The cost-effectiveness of hypertension management in low-income and middle-income countries: a review

Hypertension in low-income and middle-income countries (LMICs) is largely undiagnosed and uncontrolled, representing an untapped opportunity for public health improvement. Implementation of hypertension control strategies in low-resource settings depends in large part on cost considerations. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostova, Deliana, Spencer, Garrison, Moran, Andrew E, Cobb, Laura K, Husain, Muhammad Jami, Datta, Biplab Kumar, Matsushita, Kunihiro, Nugent, Rachel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484861/ https://www.ncbi.nlm.nih.gov/pubmed/32912853 http://dx.doi.org/10.1136/bmjgh-2019-002213

Ejemplares similares

The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review
por: Husain, Muhammad Jami, et al.
Publicado: (2022)

Blood from a stone: funding hypertension prevention, treatment, and care in low- and middle-income countries
por: Cohn, Jennifer, et al.
Publicado: (2021)

Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries
por: Moran, Andrew E., et al.
Publicado: (2022)

Assessing costs of a hypertension management program: An application of the HEARTS costing tool in a program planning workshop in Thailand
por: Husain, Muhammad Jami, et al.
Publicado: (2019)

Disease and demography: a systems-dynamic cohort-component population model to assess the implications of disease-specific mortality targets
por: Husain, Muhammad Jami, et al.
Publicado: (2021)

Hypertension in women: the role of adolescent childbearing
por: Datta, Biplab K., et al.
Publicado: (2021)

Noncommunicable disease-attributable medical expenditures, household financial stress and impoverishment in Bangladesh
por: Datta, Biplab Kumar, et al.
Publicado: (2018)

Consumption displacement in households with noncommunicable diseases in Bangladesh
por: Datta, Biplab Kumar, et al.
Publicado: (2018)

Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
por: Husain, Muhammad Jami, et al.
Publicado: (2020)

Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective
por: Nugent, Rachel A., et al.
Publicado: (2020)

Correction: Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective
por: Nugent, Rachel A., et al.
Publicado: (2020)

Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application
por: Husain, Muhammad Jami, et al.
Publicado: (2022)

Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness
por: Horton, Susan, et al.
Publicado: (2017)

Cost assessment of a program for laboratory testing of plasma trans-fatty acids in Thailand
por: Datta, Biplab Kumar, et al.
Publicado: (2021)

Cost analysis of the WHO-HEARTS program for hypertension control and CVD prevention in primary health facilities in Ethiopia
por: Beshah, Senait Alemayehu, et al.
Publicado: (2023)

Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review
por: Masyuko, Sarah, et al.
Publicado: (2021)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review
por: Brouwer, Elizabeth D., et al.
Publicado: (2015)

Innovations for effective implementation of guideline-based hypertension care in low-income and middle-income countries
por: Naik, Nitish, et al.
Publicado: (2021)

Cost-effectiveness of club-foot treatment in low-income and middle-income countries by the Ponseti method
por: Grimes, Caris E, et al.
Publicado: (2016)

Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review
por: Fung, Alastair, et al.
Publicado: (2019)

Approaches for Controlling Illicit Tobacco Trade — Nine Countries and the European Union
por: Ross, Hana, et al.
Publicado: (2015)

Telemedicine interventions for hypertension management in low- and middle-income countries: A scoping review
por: Hoffer-Hawlik, Michael, et al.
Publicado: (2021)

Interventional radiology in low- and middle-income countries
por: Jamil, Hashaam, et al.
Publicado: (2022)

Developing guidelines in low-income and middle-income countries: lessons from Kenya
por: English, Mike, et al.
Publicado: (2017)

Revisiting the association between worldwide implementation of the MPOWER package and smoking prevalence, 2008–2017
por: Husain, Muhammad Jami, et al.
Publicado: (2021)

Landscape of team-based care to manage hypertension: results from two surveys in low/middle-income countries
por: Ogungbe, Oluwabunmi, et al.
Publicado: (2023)

How much does it cost to scale up surgical systems in low-income and middle-income countries?
por: Jumbam, Desmond T., et al.
Publicado: (2019)

Management of neonatal jaundice in low-income and middle-income countries
por: Erdeve, Omer
Publicado: (2020)

Tackling antimicrobial resistance in low-income and middle-income countries
por: Pokharel, Sunil, et al.
Publicado: (2019)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Improving childhood vaccination in low-income and middle-income countries
por: eBioMedicine
Publicado: (2023)

Towards better diagnostic tools for liver injury in low-income and middle-income countries
por: Moed, Saundria, et al.
Publicado: (2019)

Considerations for modelling a broad food tax in the Philippines and other low-income and middle-income countries
por: Johnson Curtis, Christine, et al.
Publicado: (2023)

Economic Costs of Childhood Lead Exposure in Low- and Middle-Income Countries
por: Attina, Teresa M., et al.
Publicado: (2013)

The cost of dialysis in low and middle-income countries: a systematic review
por: Mushi, Lawrencia, et al.
Publicado: (2015)

Not just a number: examining coverage and content of antenatal care in low-income and middle-income countries
por: Benova, Lenka, et al.
Publicado: (2018)

The Impact and Cost of Scaling up Midwifery and Obstetrics in 58 Low- and Middle-Income Countries
por: Bartlett, Linda, et al.
Publicado: (2014)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries
por: Haider, Sabbir, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_spsng4bh853j8f7fh17ordlb32